A defective splicing machinery promotes senescence through MDM4 alternative splicing
Aging Cell · 2024
DOI: 10.1111/acel.14301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2024. Verfasst von Mathieu Deschênes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins, Alternative Splicing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Defects in the splicing machinery are implicated in various diseases, including cancer. We observed a general reduction in the expression of spliceosome components and splicing regulators in human cell lines undergoing replicative, stress‐induced, and telomere uncapping‐induced senescence. Supporting the view that defective splicing contributes to senescence, splicing inhibitors herboxidiene, and pladienolide B induced senescence in normal and cancer cell lines. Furthermore, depleting individual spliceosome components also promoted senescence. All senescence types were associated with an alternative splicing transition from the MDM4‐FL variant to MDM4‐S . The MDM4 splicing shift was reproduced when splicing was inhibited, and spliceosome components were depleted. While decreasing the level of endogenous MDM4 promoted senescence and cell survival independently of the MDM4‐S expression status, cell survival was also improved by increasing MDM4‐S . Overall, our work establishes that splicing defects modulate the alternative splicing of MDM4 to promote senescence and cell survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
- Institut du Cancer de Montréal, Montréal, Quebec, Canada.
- Department of Radiology, Radio-Oncology and Nuclear Medicine, Université de Montréal, Montréal, Quebec, Canada.
ORCID-Profile: Francis Rodier, Benoit Chabot
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Deschênes, M., Durand, M., Olivier, M. A., Pellerin-Viger, A., Rodier, F., & Chabot, B. (2024). A defective splicing machinery promotes senescence through MDM4 alternative splicing. Aging Cell. https://doi.org/10.1111/acel.14301
Vancouver
Deschênes M, Durand M, Olivier MA, Pellerin-Viger A, Rodier F, Chabot B. A defective splicing machinery promotes senescence through MDM4 alternative splicing. Aging Cell. 2024. doi:10.1111/acel.14301
BibTeX
@article{Deschnes2024,
author = {Deschênes, Mathieu and Durand, Mathieu and Olivier, Marc-Alexandre and Pellerin-Viger, Alicia and Rodier, Francis and Chabot, Benoit},
title = {A defective splicing machinery promotes senescence through MDM4 alternative splicing},
journal = {Aging Cell},
year = {2024},
doi = {10.1111/acel.14301}
}
EUVIMED